Haelly M. Metuge
Buea, SW, Cameroon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents.
Journal: Experimental parasitology
Published: July 26, 2020
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
Journal: Science translational medicine
Published: October 13, 2018
Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents.
Journal: Parasites & vectors
Published: August 10, 2018
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.
Journal: Science translational medicine
Published: May 17, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Journal: Scientific reports
Published: January 20, 2018
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models.
Journal: PLoS neglected tropical diseases
Published: December 22, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Journal: Scientific reports
Published: October 04, 2016
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
Journal: Parasites & vectors
Published: August 19, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026